This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydroxychloroquine 200 mg tablets. The contract has a ceiling value of $1,152.60 and runs through January 29, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,464 tablets of Hydroxychloroquine 200 mg. The $2,909.44 firm fixed-price contract has a completion date of September 15, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $1,082.52 delivery order issued by the Defense Logistics Agency (DLA) for the supply of 4,556,834,433 units of hydroxychloroquine 200 mg tablets. The contract is a firm-fixed-price, full and open competition award with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This contract award, with an ID of SPE2DB20D3104|SPE2DB22FV7Y7, is for the delivery of 4557731030 - hydroxychloroquine 200 mg tablets in units of 50. The $1,326.33 ceiling value contract was awarded on July 7, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 8, 2022. This appears to be a specific order under a larger...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,182.82 fixed-price contract is for the delivery of Plaquenil (hydroxychloroquine) 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of pharmaceutical products, including 100-count bottles of the drug Plaquenil (hydroxychloroquine sulfate 200 mg tablets), with a ceiling value of $12,565.42 and a period of performance through February 2023. The...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.40 firm-fixed-price contract is for the delivery of Plaquenil 200 mg tablets. The contract has a completion date of March 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, with a ceiling value of $16,165.52 and a period of performance ending on January 27, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...